Skip to main content
. 2017 Jun 14;12:98. doi: 10.1186/s13014-017-0837-5

Fig. 2.

Fig. 2

Biochemical recurrence free survival for low and intermediate risk patients (significantly higher rates for LDR vs. EBRT, p = 0.03, and HDR-BT vs. EBRT, p = 0.03)